Share |

PrintPrintable version



Bayer Settles More Than 2,900 Lawsuits

|

Associated Press
01.26.2005, 05:54 AM

German drug maker Bayer AG said Wednesday it has now settled more than 2,900 suits related to its cholesterol-lowering drug Lipobay, or Baycol, paying more than US$1.1 billion in out-of-court deals.

Bayer pulled Lipobay, marketed as Baycol in the United States, in 2001 after it was linked to a rare muscle-wasting syndrome and about 100 patient deaths.

In a regular posting to its Web site, the Leverkusen-based company said it has now settled 2,933 cases and agreed to pay a total of US$1.113 billion without admitting liability. Some 6,359 cases are still pending.

In November the company said it had reached settlements in 2,895 cases and paid some US$1.1 billion in out-of-court deals.



  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)




Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Other sites of ours